We are live on
!
Find out more
BIOS
BioPlus Acquisition Corp. Class A Ordinary Shares
BIOS
BIOS
Delisted
BIOS was delisted on the 6th of October, 2023.
66 hedge funds and large institutions have $213M invested in BioPlus Acquisition Corp. Class A Ordinary Shares in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
7% more capital invested
Capital invested by funds: $200M → $213M (+$13.5M)
0% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 11
1% less funds holding
Funds holding: 67 → 66 (-1)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
Holders
66
Holders Change
-1
Holders Change %
-1.49%
% of All Funds
1.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
11
Reduced
11
Closed
8
Calls
$103K
Puts
–
Net Calls
+$103K
Net Calls Change
+$2K
Top Buyers
| 1 |
Calamos Advisors
Naperville,
Illinois
|
+$10.1M |
| 2 |
CF
Cantor Fitzgerald
New York
|
+$5.81M |
| 3 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$2.72M |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
+$2.54M |
| 5 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$1.76M |
Top Sellers
| 1 |
HCM
Highbridge Capital Management
New York
|
-$5.97M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$4.7M |
| 3 |
Citigroup
New York
|
-$3.96M |
| 4 |
Parallax Volatility Advisers
San Francisco,
California
|
-$2.23M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$1.52M |
